Sign In
Buy FENC
$9.14
-0.84 (-8.42%)
At Close: Jun 03, 2026
Is Fennec Pharmaceuticals Inc. (FENC) A Good Stock To Buy?
11:21pm, Friday, 20'th Dec 2019
Hedge funds are known to underperform the bull markets but that's not because they are bad at investing. Truth be told, most hedge fund managers and other smaller players within this industry are very
Catalyst Focuses on Firdapse Label Expansion Amid Competition
02:39pm, Friday, 29'th Nov 2019
Catalyst (CPRX) focuses on the development of Firdapse for additional indications.
Fennec Pharmaceuticals Inc. (FENC) Shares March Higher, Can It Continue?
02:22pm, Wednesday, 27'th Nov 2019
As of late, it has definitely been a great time to be an investor in Fennec Pharmaceuticals Inc. (FENC).
Fennec Provides Business Update and Announces Third Quarter 2019 Financial Results
11:00am, Tuesday, 12'th Nov 2019
NDA (New Drug Application) for PEDMARKTM to be completed in early 2020Strong financial position with $15.2 million in cash and no debt RESEARCH TRIANGLE PARK, N.C., Nov. 12,.
Companies Like Fennec Pharmaceuticals (NASDAQ:FENC) Are In A Position To Invest In Growth
04:45pm, Thursday, 17'th Oct 2019
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Fennec to Present at the 2019 Cantor Global Healthcare Conference on October 4, 2019
10:00am, Wednesday, 02'nd Oct 2019
RESEARCH TRIANGLE PARK, N.C., Oct. 02, 2019 -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company focused on the development of PEDMARKTM.
Fennec Appoints Jodi A. Cook, PhD to Its Board of Directors
10:00am, Tuesday, 24'th Sep 2019
TSX: FRX), a specialty pharmaceutical company focused on the development of PEDMARKTM (a unique formulation of sodium thiosulfate (STS)) for the prevention of platinum-induced ototoxicity in pediatric
